Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac for Macular Thickness in Diabetic Eyes After Cataract Surgery
NCT02306031Phase 2
Key facts
- Status
- Unknown
- Start
- Jun 2013
- Primary completion
- Jun 2014
- Countries
- 1
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Modality
- Small Molecules
- Drugs
- diclofenac
- Conditions
- macular edema
01
Overview
Phase 2, randomised, double-blind trial of diclofenac in macular edema, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Macular thickness changes at 90 days. Status: unknown.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Diabetic patients with non-proliferative diabetic retinopathy undergoing phacoemulsification, excluding those with existing macular edema or other retinal conditions.
04
Endpoints
Primary
Macular thickness changes
Beyond the preview
Go deeper on NCT02306031.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306031.